Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases

Health

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-Mediated Diseases

By Eli Lilly

Ventyx's clinical pipeline includes multiple small molecules with potential for oral therapies addressing chronic inflammation Acquisition builds on Lilly's established capabilities in inflammatory-mediated diseases INDIANAPOLIS, Jan. 7, 2026 /PRNews ...Read more

Related Posts

Trump revives Monroe Doctrine

Trump revives Monroe Doctrine

Jan 05, 2026
U.S. Pledges $2 Billion for U.N. Aid but Trump Administration Tells Agencies to ‘Adapt, Shrink, or Die’

U.S. Pledges $2 Billion for U.N. Aid but Trump Administration Tells Agencies to ‘Adapt, Shrink, or Die’

Dec 29, 2025
Live Updates: Senate Advances Measure to Curb Trump’s Use of Force in Venezuela

Live Updates: Senate Advances Measure to Curb Trump’s Use of Force in Venezuela

Jan 08, 2026
New York state sees highest number of flu cases ever in a single week

New York state sees highest number of flu cases ever in a single week

Dec 29, 2025
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.